tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: BioNTech SE (BNTX), Ayala Pharmaceuticals (AYLA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNTech SE (BNTXResearch Report) and Ayala Pharmaceuticals (AYLAResearch Report) with bullish sentiments.

BioNTech SE (BNTX)

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on BioNTech SE, with a price target of $298.00. The company’s shares closed last Tuesday at $161.03, close to its 52-week low of $117.08.

According to TipRanks.com, Burns ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -20.0% and a 27.0% success rate. Burns covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Black Diamond Therapeutics.

BioNTech SE has an analyst consensus of Hold, with a price target consensus of $229.67, representing a 51.7% upside. In a report issued on June 27, Berenberg Bank also maintained a Buy rating on the stock with a $350.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Ayala Pharmaceuticals (AYLA)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Ayala Pharmaceuticals, with a price target of $18.00. The company’s shares closed last Tuesday at $1.09, close to its 52-week low of $0.96.

According to TipRanks.com, Selvaraju has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -40.3% and a 14.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Santhera Pharmaceuticals Holding AG, Oramed Pharmaceuticals, and Oncternal Therapeutics.

Ayala Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $15.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BNTX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed